Table 1.
IDCHR N = 77 (59 ♂, 18 ♀) |
IDCLR N = 14 (11 ♂, 3 ♀) |
p-value | |
---|---|---|---|
Follow-up duration [months] | 27 [17; 37] | 30 [21; 38] | n.s. |
Age (years) | 55 [50; 60] | 56 [50; 63] | n.s. |
LVEF (%) | 29 [27; 37] | 35 [27; 46] | n.s. |
LVEDD (mm) | 69 [61; 79] | 61 [58; 68] | n.s. |
LVESD (mm) | 60 [53; 69] | 49 [44; 56] | 0.0028 |
NYHA | 3 [2; 4] | 2 [2; 3] | 0.0024 |
IDCHR and IDCLR, high risk and low risk group of patients with dilated cardiomyopathy; N, number of patients within the groups (♂ = Male; ♀ = Female); LVEF, Left ventricular ejection fraction; LVEDD, Left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; NYHA, New York heart association index.